Jeff Yass’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$738K Sell
50,564
-51,052
-50% -$675K ﹤0.01% 8976
2026
Q1
$1.4M Buy
101,616
+21,632
+27% +$326K ﹤0.01% 7066
2025
Q4
$1.44M Sell
79,984
-196,682
-71% -$3.53M ﹤0.01% 6353
2025
Q3
$5.13M Buy
276,666
+247,263
+841% +$3.88M ﹤0.01% 4055
2025
Q2
$470K Sell
29,403
-9,473
-24% -$169K ﹤0.01% 9317
2025
Q1
$755K Buy
38,876
+24,112
+163% +$507K ﹤0.01% 7963
2024
Q4
$325K Sell
14,764
-85,203
-85% -$1.64M ﹤0.01% 9652
2024
Q3
$1.68M Sell
99,967
-50,095
-33% -$743K ﹤0.01% 5637
2024
Q2
$1.79M Buy
+150,062
New +$1.68M ﹤0.01% 5309
2024
Q1
Sell
-102,838
Closed -$1.05M 12284
2023
Q4
$891K Buy
102,838
+42,045
+69% +$327K ﹤0.01% 7269
2023
Q3
$465K Sell
60,793
-30,997
-34% -$233K ﹤0.01% 8402
2023
Q2
$661K Sell
91,790
-114,312
-55% -$666K ﹤0.01% 7661
2023
Q1
$1.26M Buy
206,102
+158,242
+331% +$858K ﹤0.01% 6231
2022
Q4
$209K Buy
+47,860
New +$214K ﹤0.01% 10027
2022
Q3
Sell
-16,225
Closed -$81.3K 13246
2022
Q2
$83K Sell
16,225
-168,999
-91% -$879K ﹤0.01% 11639
2022
Q1
$1.19M Buy
185,224
+43,916
+31% +$291K ﹤0.01% 6687
2021
Q4
$1.13M Buy
+141,308
New +$1.33M ﹤0.01% 6962

Other funds holding CLBT

Jeff Yass's CLBT Position: Q2 2026 in Review

Jeff Yass reduced its Cellebrite (CLBT) stake by 50% in Q2 2026, selling an estimated $675K and leaving 50,564 shares worth $738K. The position accounts for ﹤0.01% of the portfolio, ranked #8976.

Jeff Yass first reported a position in CLBT in Q4 2021 and has held it in 17 quarters since. The position peaked at $5.13M in Q3 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Jeff Yass held 50,564 shares of Cellebrite worth $738K as of Q2 2026.
  • Jeff Yass sold 51,052 Cellebrite shares in Q2 2026, an estimated $675K.
  • Cellebrite made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8976 holding.
  • Jeff Yass first reported a position in Cellebrite in Q4 2021 and has held it in 17 quarters since.
  • Jeff Yass's Cellebrite position peaked at $5.13M in Q3 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.